Literature DB >> 14412753

Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis.

C M KUNIN, A J GLAZKO, M FINLAND.   

Abstract

Entities:  

Keywords:  CHLORAMPHENICOL/blood; KIDNEY DISEASES/blood; LIVER CIRRHOSIS/blood

Mesh：

Substances：

Year:  1959        PMID： 14412753      PMCID： PMC293281          DOI： 10.1172/JCI103928

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  24 in total

1.  Demethylchlortetracycline; a new tetracycline antibiotic that yields greater and more sustained antibacterial activity.

Authors:  C M KUNIN; M FINLAND
Journal:  N Engl J Med       Date:  1958-11-20       Impact factor: 91.245

2.  Urinary glucuronic acid excretion in liver disease and the effect of a salicylamide load.

Authors:  H T BARNIVILLE; R MISK
Journal:  Br Med J       Date:  1959-02-07

3.  Persistence of antibiotics in blood of patients with acute renal failure. III. Penicillin, streptomycin, erythromycin and kanamycin.

Authors:  C M KUNIN; M FINLAND
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

4.  Persistence of antibiotics in blood of patients with acute renal failure. I. Tetracycline and chlortetracycline.

Authors:  C M KUNIN; S B REES; J P MERRILL; M FINLAND
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

5.  Changes in iron metabolism in early chloramphenicol toxicity.

Authors:  D RUBIN; A S WEISBERGER; R E BOTTI; J P STORAASLI
Journal:  J Clin Invest       Date:  1958-09       Impact factor: 14.808

6.  Jaundice and bilirubin metabolism.

Authors:  R SCHMID
Journal:  AMA Arch Intern Med       Date:  1958-03

7.  Effect of N-acetyl-para-aminophenol on plasma levels of 17-hydroxycorticosteroids.

Authors:  G CORTE; W JOHNSON
Journal:  Proc Soc Exp Biol Med       Date:  1958-04

8.  Renal function in renal diseases.

Authors:  S E BRADLEY; G P BRADLEY; C J TYSON; J J CURRY; W D BLAKE
Journal:  Am J Med       Date:  1950-12       Impact factor: 4.965

9.  The decomposition of chloromycetin (chloramphenicol) by microorganisms.

Authors:  G N SMITH; C S WORREL
Journal:  Arch Biochem       Date:  1950-09

10.  Observations on the metabolic disposition of chloramphenicol (chloromycetin) in the rat.

Authors:  A J GLAZKO; W A DILL; L M WOLF
Journal:  J Pharmacol Exp Ther       Date:  1952-04       Impact factor: 4.030
View more
  34 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  [CHLORAMPHENICOL LEVEL IN RENAL FUNCTION DISORDERS].

Authors:  D HOEFFLER; F SCHELER; W WIGGER
Journal:  Klin Wochenschr       Date:  1965-02-15

3.  Persistence of antibiotics in blood of patients with acute renal failure. III. Penicillin, streptomycin, erythromycin and kanamycin.

Authors:  C M KUNIN; M FINLAND
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

4.  Persistence of antibiotics in blood of patients with acute renal failure. I. Tetracycline and chlortetracycline.

Authors:  C M KUNIN; S B REES; J P MERRILL; M FINLAND
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

5.  The influence of furosemide on the renal excretion of chloramphenicol and its metabolites.

Authors:  O Schück; J Grafnetterová; V Prát; E Kotanová
Journal:  Experientia       Date:  1975-12-15

6.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.

Authors:  P J Ambrose
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

8.  A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol.

Authors:  R A Branch; J James; A E Read
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

Review 9.  Drug prescribing in hepatobiliary disease.

Authors:  R K Roberts; P V Desmond; S Schenker
Journal:  Drugs       Date:  1979-03       Impact factor: 9.546

10.  The effects of peritoneal dialysis on the physiological disposition of oxacillin, ampicillin and tetracycline in patients with renal disease.

Authors:  J Ruedy
Journal:  Can Med Assoc J       Date:  1966-02-05       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.